Sepsis Diagnosis via Integrated Breath Sensing System with Change-Point Detection for Real-Time Point-of-Care

MSCA (Marie Skłodowska-Curie)HORIZON-TMA-MSCA-PF-EFID: 101062837
EC Contribution
€1,485
Consortium Size
1 orgs
Start Year
2022
Summary

Every 2.8 seconds someone dies from sepsis: 11 million people annually, out of which children under 5 years old. Septic shock is the potentially fatal body’s dysregulated response to pathogens that spread through blood circulation, including viruses like SARS-CoV-2. Half of sepsis cases happen in ICUs with 42% morality, with costs of €30 000 per case and €20 billion per year. Current diagnosis protocols rely on observation of the clinical symptoms to initiate regular monitoring of patients’ vital signs. Blood analyses and other tests identify the source of infection within 2-5 days, during which broad-spectrum antibiotics are administered, contributing to antibiotic resistance. Every hour of delay increases the mortality rate by 5-10%. Hence, early diagnosis of the infection source is a major step towards treatment. Pre-clinical and commercial point-of-care devices reduce the analysis time to few hours but still rely on the manifestation of clinical symptoms and invasive blood-based assays. SepsISensoR will advance the sepsis diagnosis protocol by non-invasive real-time monitoring of ICU patients’ breath to detect pre-symptomatic signs of sepsis based on transient changes of gas biomarkers in early sepsis stages. This will be achieved by: (a) integrating commercial gas sensors with fabricated preconcentrators on a single chip for high sensitivity, efficient and scalable multiple gas sensing; (b) using on-line change-point detection (CPD) on the breath signal to identify temporal variations of single- and multi-gas concentration; (c) validating the system with gases released from in vitro and in vivo models of sepsis. SepsISensoR will go beyond the state-of-the-art by reducing diagnosis time, and in turn reducing time in ICUs, cost, and sepsis fatalities. This aligns with Pillar I Excellent Science MSCA fellowship under the European Research Council and Key Strategic Orientation A with Cluster 1 of the Work Programme on technologies for healthy society.

Consortium (1)

Project Results (7)

Source: CORDIS, the EU research results database.

Publications (5)
Advancing Breath‐Based Diagnostics: 3D Mesh SERS Sensor Via Dielectrophoretic Alignment of Solution‐Processed Au Nanoparticle‐Decorated TiO<sub>2</sub> Nanowires
Advanced Sensor Research· 2025DOI
Marios Constantinou, Christoforos Panteli, Louiza Potamiti, Mihalis I. Panayiotidis, Agapios Agapiou, Sotirios Christodoulou, Chrysafis Andreou
Breath Analysis via Surface Enhanced Raman Spectroscopy
ACS Sensors· 2025DOI
Adrián Fernández-Lodeiro, Marios Constantinou, Christoforos Panteli, Agapios Agapiou, Chrysafis Andreou
Gas Sensor with Integrated Preconcentrator for Time-Based Bacterial Growth Monitoring
2025 IEEE BioSensors Conference (BioSensors)· 2025DOI
Christoforos Panteli, Marios Stylianou, Andreas Anastasiou, Chrysafis Andreou
Gas-Phase Detection of UTI-Causing Bacteria Using Off-the-Shelf Gas Sensors and Change-Point Detection
IEEE Sensors Journal· 2024DOI
Christoforos Panteli; Marios Stylianou; Andreas Anastasiou; Chrysafis Andreou
Rapid Detection of Bacterial Infection Using Gas Phase Time Series Analysis
2023 IEEE SENSORS· 2023DOI
Christoforos Panteli, Marios Stylianou, Andreas Anastasiou, Chrysafis Andreou
Deliverables (2)